Edwards Lifesciences

Public Kalshi markets

Will there be a U.S. recession in 2026?

Edwards Lifesciences is included because procedure volumes, payer budgets, and funding conditions can shift with the macro backdrop.

14.5%14¢ / 15¢Quote as of 2026.05.27 02:23 UTC2027.01.31

02Rates

Will the 30-year U.S. Treasury par yield for Q2 2026 be above 5.30%?

Edwards Lifesciences is included because long-rate outcomes shape financing costs, valuation backdrop, and capital allocation.

50%0¢ / 100¢Quote as of 2026.05.27 02:23 UTCWide quote2026.06.30

03Public health event

Will there be a pandemic in 2026?

Edwards Lifesciences is included because public-health disruptions can affect Health Care Equipment demand, staffing, and operating continuity.

10.5%10¢ / 11¢Quote as of 2026.05.27 02:23 UTC2027.01.01

04Inflation

CPI year-over-year for May 2026

Edwards Lifesciences is included because inflation can affect Health Care Equipment costs, pricing, and demand.

40%39¢ / 41¢Quote as of 2026.05.27 02:23 UTC2026.06.10

05Demand cycle

Will more than 60,000 jobs be added in July 2026?

Edwards Lifesciences is included because procedure volumes, payer budgets, and funding conditions can shift with the macro backdrop.

54.5%49¢ / 60¢Quote as of 2026.05.27 02:23 UTC2026.08.07

Exposure context

Edwards Lifesciences's five markets cover demand cycle, rates backdrop, and event shocks. The traditional-market references below are context for how investors usually express those exposures; they are not claims about company hedging activity.

Traditional-market context

single-name equity optionssector ETF overlaysrevenue sensitivity analysis

Company-level context only, not a claim about trading activity.